Acumen Pharmaceuticals In... (ABOS)
NASDAQ: ABOS
· Real-Time Price · USD
1.48
0.21 (16.54%)
At close: Sep 25, 2025, 3:59 PM
1.51
1.97%
After-hours: Sep 25, 2025, 05:17 PM EDT
16.54% (1D)
| Bid | 1.47 |
| Market Cap | 89.65M |
| Revenue (ttm) | 178K |
| Net Income (ttm) | -136.66M |
| EPS (ttm) | -2.27 |
| PE Ratio (ttm) | -0.65 |
| Forward PE | -0.74 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.54 |
| Volume | 1,275,338 |
| Avg. Volume (20D) | 413,314 |
| Open | 1.31 |
| Previous Close | 1.27 |
| Day's Range | 1.30 - 1.54 |
| 52-Week Range | 0.85 - 3.36 |
| Beta | 0.14 |
| Ex-Dividend Date | n/a |
About ABOS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ABOS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ABOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-11.27%
Acumen Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
1 month ago · seekingalpha.com
Acumen Pharmaceuticals, Inc. (ABOS) Q2 2025 Earnings Call TranscriptAcumen Pharmaceuticals, Inc. (NASDAQ:ABOS ) Q2 2025 Earnings Conference Call August 12, 2025 8:00 AM ET Company Participants Alex Braun - VP & Head of Investor Relations Daniel J. O'Connell - CEO & Di...
